BFM
IMVT icon

Boothbay Fund Management’s Immunovant IMVT Stock Holding History

Boothbay Fund Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-64,796
Closed -$1.91M – 1763
2024
Q2 		$1.71M Sell
64,796
-221
-0.3% -$6.29K 0.04% 558
2024
Q1 		$2.1M Buy
65,017
+15,427
+31% +$563K 0.04% 487
2023
Q4 		$2.09M Sell
49,590
-5,516
-10% -$203K 0.05% 468
2023
Q3 		$2.12M Buy
+55,106
New +$1.25M 0.05% 473
2023
Q2 		– Sell
-138,000
Closed -$2.57M – 2021
2023
Q1 		$2.14M Sell
138,000
-38,388
-22% -$666K 0.04% 628
2022
Q4 		$3.13M Buy
176,388
+34,253
+24% +$431K 0.07% 407
2022
Q3 		$793K Buy
+142,135
New +$695K 0.02% 994
2021
Q4 		– Sell
-32,233
Closed -$280K – 2020
2021
Q3 		$280K Sell
32,233
-12,726
-28% -$115K 0.01% 1366
2021
Q2 		$475K Buy
+44,959
New +$628K 0.02% 1032
2021
Q1 		– Sell
-28,568
Closed -$753K – 1651
2020
Q4 		$1.32M Sell
28,568
-10,464
-27% -$484K 0.05% 402
2020
Q3 		$1.37M Buy
39,032
+3,525
+10% +$106K 0.08% 330
2020
Q2 		$865K Sell
35,507
-84,097
-70% -$1.8M 0.06% 433
2020
Q1 		$1.86M Buy
119,604
+34,941
+41% +$526K 0.15% 165
2019
Q4 		$1.34M Sell
84,663
-351,601
-81% -$3.94M 0.12% 240
2019
Q3 		$4.33M Buy
+436,264
New +$4.31M 0.4% 41

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Boothbay Fund Management's IMVT Position: Q3 2024 in Review

Boothbay Fund Management sold out of Immunovant (IMVT) in Q3 2024, closing a stake of 64,796 shares — an estimated $1.91M sold.

Boothbay Fund Management first reported a position in IMVT in Q3 2019 and held it in 15 quarters. The position peaked at $4.33M in Q3 2019. 181 funds tracked by Wall St. Rank hold IMVT as of Q3 2024.

  • Boothbay Fund Management reported no remaining Immunovant position as of Q3 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 64,796 Immunovant shares in Q3 2024, an estimated $1.91M.
  • Boothbay Fund Management first reported a position in Immunovant in Q3 2019 and held it in 15 quarters.
  • Boothbay Fund Management's Immunovant position peaked at $4.33M in Q3 2019.
  • 181 funds tracked by Wall St. Rank held Immunovant as of Q3 2024.

Based on Boothbay Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.